GlassScriptPhysician profile
Brett Michael Milford
NPI 1306191341
$6,271.99
in general payments reported to CMS, 2019-2025
32 companies · $904 in 2025
The $904 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $120 · 2021: $859 · 2022: $3,226 · 2023: $532 · 2024: $532 · 2025: $904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,931 · Travel and Lodging: $36.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,931.33 |
| Travel and Lodging | $36.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,101.13 | 2021-2024 | Indigo System |
| Cvrx, INC. | $487.35 | 2021-2023 | Barostim Neo System |
| Abbott Laboratories | $387.66 | 2020-2024 | Assurity |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $250.70 | 2020-2025 | Lifevest |
| Cleerly, INC. | $214.14 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Janssen Pharmaceuticals, INC | $199.67 | 2019-2023 | Xarelto |
| Biotronik INC. | $172.03 | 2019-2023 | Biomonitor |
| Edwards Lifesciences Corporation | $142.14 | 2025 | |
| Abiomed | $138.12 | 2021 | |
| Novartis Pharmaceuticals Corporation | $119.53 | 2024-2025 | |
| Boston Scientific Corporation | $118.57 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.30 | 2023-2025 | Jardiance |
| Pfizer INC. | $100.51 | 2023-2025 | |
| Shockwave Medical, INC | $99.65 | 2025 | |
| Merck Sharp & Dohme LLC | $75.23 | 2023-2025 | Keytruda, Verquvo |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $52.60 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $49.19 | 2022-2024 | Venovo |
| Asahi Intecc USA, INC. | $46.11 | 2019 | |
| Alnylam Pharmaceuticals INC. | $46.01 | 2024-2025 | Onpattro |
| Medtronic, INC. | $44.27 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $43.36 | 2019-2023 | Farxiga |
| Novo Nordisk INC | $42.28 | 2024-2025 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $34.17 | 2024-2025 | Eliquis, Camzyos |
| Cardiovascular Systems INC. | $28.58 | 2020-2021 | |
| Bridgebio Pharma, INC. | $27.06 | 2025 | Attruby |
| Philips North America LLC | $24.83 | 2024 | (Ck7) Extended Holter |
| Tersera Therapeutics LLC | $22.42 | 2025 | Quzyttir |
| Daiichi Sankyo INC. | $21.66 | 2024 | Injectafer |
| Esperion Therapeutics, INC. | $19.12 | 2025 | Nexletol |
| Amgen INC. | $19.06 | 2025 | Repatha |
| Sobi, INC | $18.51 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $17.03 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Milford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.